Veracyte, Inc. VCYT

$44.19 -4.02% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-09-22 View →
4 FORM 4 2026-09-16 View →
8-K 8-K 2026-09-14 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-04 View →
4 FORM 4 2026-09-03 View →
10-Q 10-Q 2026-07-31 View →
8-K 8-K 2026-07-30 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
4 FORM 4 2026-06-15 View →
8-K 8-K 2026-06-11 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-06-04 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-22 View →
4 FORM 4 2026-05-08 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-05 View →
DEF 14A DEF 14A 2026-04-22 View →
4 FORM 4 2026-04-14 View →
8-K 8-K 2026-03-16 View →
4 FORM 4 2026-03-10 View →
4 FORM 4 2026-03-10 View →
4 FORM 4 2026-03-10 View →
4 FORM 4 2026-03-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$44.19
Market Cap
$3.70 billion
52-Week Range
$28.55 – $60.91
Average Volume
1.42 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.